COVID-19, and more rarely the mRNA-based COVID-19 vaccine, can lead to inflammation of heart tissue in some individuals. A ...
Meanwhile, GC Biopharma was recently selected as a recipient of Phase 1 clinical research support under the Korea Disease Control and Prevention Agency (KDCA)'s 'mRNA Vaccine Development Support ...
The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...
The independent journey of CureVac as a publicly traded company has reached its conclusion. Following the expiration of the acceptance period, BioNTech has s ...
The Chosun Ilbo on MSN
mRNA treatment rejuvenates immune cells in aging mice
Old mice experienced "rejuvenation" after receiving this injection. It is an injectable treatment utilizing ribonucleic acid ...
Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...
As support from the U.S. government has evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA ...
Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...
An innovative three-color method for capturing images of mRNA inside live mammalian cells has been developed by UMass Amherst chemists. Because RNA is both incredibly important to human life and ...
TUCKER, GA. — The US Poultry & Egg Association (USPOULTRY) and its Foundation announced the completion of a research project that developed messenger ribonucleic acid (mRNA) vaccines for two major ...
A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback